GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » 3-Year EPS without NRI Growth Rate

New Horizon Health (HKSE:06606) 3-Year EPS without NRI Growth Rate : 24.50% (As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health 3-Year EPS without NRI Growth Rate?

New Horizon Health's EPS without NRI for the six months ended in Jun. 2023 was HK$0.30.

During the past 12 months, New Horizon Health's average EPS without NRI Growth Rate was -29.10% per year. During the past 3 years, the average EPS without NRI Growth Rate was 24.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 5 years, the highest 3-Year average EPS without NRI Growth Rate of New Horizon Health was 24.50% per year. The lowest was -153.40% per year. And the median was -64.45% per year.


Competitive Comparison of New Horizon Health's 3-Year EPS without NRI Growth Rate

For the Medical Devices subindustry, New Horizon Health's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Horizon Health's 3-Year EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where New Horizon Health's 3-Year EPS without NRI Growth Rate falls into.



New Horizon Health 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


New Horizon Health  (HKSE:06606) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


New Horizon Health 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of New Horizon Health's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


New Horizon Health (HKSE:06606) Business Description

Traded in Other Exchanges
Address
400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
Executives
Invesco Advisers, Inc. 2102 Investment manager
Chen Yiyou 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Bancasa Holding Limited 2201 Interest of corporation controlled by you
Mst Development Limited 2101 Beneficial owner
Yao Naxin 2305 Beneficiary of a trust
Janus Henderson Group Plc 2102 Investment manager
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
Invesco Developing Markets Fund 2106 Person having a security interest in shares
Zhu Yeqing 2101 Beneficial owner
Qiming Venture Partners V, L.p.
Qiming Gp V, L.p.
Qiming Corporate Gp V, Ltd.
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you

New Horizon Health (HKSE:06606) Headlines

No Headlines